Benign prostatic hyperplasia (BPH), benign prostatic enlargement (BPE) and lower urinary
tract symptoms (LUTS) belong to the most frequent diseases in ageing men. Beyond the 6th …

Benign prostatic hyperplasia (BPH) is the most common benign proliferative disease among
aging men. Androgens play a key role in the development and growth of the male genital …

Evasion of apoptosis is a major contributing factor to the development of chemo-and
radiotherapy resistance. Therefore, activation of non-apoptotic programmed cell death …

The relationship between metformin and prostate cancer (PCa) remains controversial. To
clarify this association, the PubMed, Embase and Cochrane library databases were …

Dysfunction of the lower urinary tract (LUT) including urinary bladder and urethra (and
prostate in men) is one of the most frequent complications of diabetes and can manifest as …

Metabolic syndrome (MetS) is a cluster of metabolic abnormalities related to central
adiposity and insulin resistance. Its importance is increasingly recognized as it associates …

Metformin is the first-line oral antidiabetic drug that shows multiple pleiotropic effects of anti-
inflamation, anti-cancer, anti-aging, anti-microbia, anti-atherosclerosis, and immune …

Benign prostatic hyperplasia (BPH) is a common male disorder. Febuxostat is a non-purine,
selective inhibitor of xanthine oxidase (XO), which has a strong antioxidant capacity and …

Benign prostate hyperplasia (BPH) is a common age-related health problem affecting almost
3 out of 4 men in their sixties. Chrysin is a dietary phytoestrogen found naturally in bee …

Metabolic syndrome (MetS) is an immense health issue that causes serious complications in
aging males including BPH. Icariin (ICA) is a flavonol glycoside that exerts a plethora of …